Wednesday, 18 November 2026European Markets

PCI BIOTECH HOLD Stock Was 13.17% Up On Wednesday

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

(VIANEWS) - The Market ended the session with PCI BIOTECH HOLD (PCIB.OL) rising 13.17% to kr2.32 on Wednesday while Oslo Børs Benchmark Index_GI slid 0.53% to kr1,227.58.

PCI BIOTECH HOLD's last close was kr2.05, 65.6% under its 52-week high of kr5.96.

About PCI BIOTECH HOLD

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in pre-clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Olix Pharmaceuticals, Aposense, IMV Immunovaccine, MDimune, eTheRNA, and Immunicum. PCI Biotech Holding ASA was incorporated in 2007 and is based in Oslo, Norway.

Earnings Per Share

As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-0.93.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -53.97%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 80.5%, now sitting on 3.79M for the twelve trailing months.

Yearly Top and Bottom Value

PCI BIOTECH HOLD's stock is valued at kr2.32 at 22:34 EST, way below its 52-week high of kr5.96 and way higher than its 52-week low of kr1.52.

Volatility

PCI BIOTECH HOLD's last week, last month's, and last quarter's current intraday variation average was a negative 8.43%, a positive 1.57%, and a positive 4.65%.

PCI BIOTECH HOLD's highest amplitude of average volatility was 8.43% (last week), 6.83% (last month), and 4.65% (last quarter).

Moving Average

PCI BIOTECH HOLD's worth is way higher than its 50-day moving average of kr1.97 and way above its 200-day moving average of kr2.09.

More news about PCI BIOTECH HOLD (PCIB.OL).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

Spotted an error? Use “Correct this article” (bottom right), or select any sentence, to report it or respond to that point.

  1. Published before we listed source documents with each article.
  2. Published 21 Jun 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›